Amgen Inc
(AMGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,989,000 | 11,969,000 | 6,630,000 | 6,112,000 | 6,266,000 |
| Marketable Securities | 48,000 | 952,000 | 1,452,000 | 4,454,000 | 4,381,000 |
| Receivables | 4,895,000 | 4,765,000 | 4,479,000 | 4,423,000 | 4,525,000 |
| Inventories | 4,086,000 | 4,152,000 | 4,115,000 | 4,017,000 | 3,893,000 |
| Other current assets | 2,367,000 | 2,542,000 | 2,423,000 | 2,293,000 | 2,079,000 |
| TOTAL | $19,385,000 | $24,380,000 | $19,099,000 | $21,299,000 | $21,144,000 |
| Non-Current Assets | |||||
| PPE Net | 5,184,000 | 4,982,000 | 4,906,000 | 4,855,000 | 4,889,000 |
| Intangibles | 30,072,000 | 29,324,000 | 29,984,000 | 30,620,000 | 31,276,000 |
| Other Non-Current Assets | 6,524,000 | 6,307,000 | 5,784,000 | 5,765,000 | 5,639,000 |
| TOTAL | $41,780,000 | $40,613,000 | $40,674,000 | $41,240,000 | $41,804,000 |
| Total Assets | $61,165,000 | $64,993,000 | $59,773,000 | $62,539,000 | $62,948,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 87,000 | 4,288,000 | 4,324,000 | 1,556,000 | 91,000 |
| Accounts payable and accrued liabilities | 1,366,000 | 1,171,000 | 1,277,000 | 1,396,000 | 1,421,000 |
| Accrued Expenses | 10,731,000 | 9,383,000 | 8,984,000 | 9,917,000 | 10,141,000 |
| TOTAL | $12,184,000 | $14,842,000 | $14,585,000 | $12,869,000 | $11,653,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,222,000 | 33,291,000 | 28,458,000 | 31,129,000 | 32,895,000 |
| Other Non-Current Liabilities | 9,059,000 | 8,643,000 | 8,483,000 | 9,207,000 | 8,991,000 |
| TOTAL | $42,281,000 | $41,934,000 | $36,941,000 | $40,336,000 | $41,886,000 |
| Total Liabilities | $54,465,000 | $56,776,000 | $51,526,000 | $53,205,000 | $53,539,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 557,029 | 563,266 | 567,852 | 574,554 | 577,566 |
| Common Shares | 32,096,000 | 31,989,000 | 31,877,000 | 31,806,000 | 31,802,000 |
| Retained earnings | -24,600,000 | -22,964,000 | -22,762,000 | -21,639,000 | -21,408,000 |
| Other shareholders' equity | -796,000 | -808,000 | -868,000 | -833,000 | -985,000 |
| TOTAL | $6,700,000 | $8,217,000 | $8,247,000 | $9,334,000 | $9,409,000 |
| Total Liabilities And Equity | $61,165,000 | $64,993,000 | $59,773,000 | $62,539,000 | $62,948,000 |